Immunization with subunit antigens prevents rectal transmission of SIV in monkeys (pages 767–775).
Article PDF
References
Marthas, M. et al. Efficacy of live-attenuated and whole-inactivated simian immunodeficiency virus vaccines against intravenous and intravaginal challenge. in Vaccines 1992 (ed. Brown, F., Chanock, R.M., Ginsberg, H.S. & Lerner, R.A.) 117–122 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992).
Miller, C.J., Alexander, N.J., Vogel, P., Anderson, J. & Marx, P.A. Mechanism of genital transmission of SIV: A hypothesis based on transmission studies and the location of SIV in the genital tract of chronically infected female rhesus macaques. J. Med. Primatol. 21, 64–68 (1992).
Miller, C.J., McGhee, J.R. & Gardner, M.B. Mucosal immunity, HIV transmission and AIDS. Lab. Invest. 68, 129–145 (1992).
Clerici, M. et al. T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaques. AIDS 8, 1391–1395 (1994).
Cranage, M.P. et al. Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virus. Lancet 339, 273–274 (1992).
Lehner, T. et al. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques. Nature Med. 2, 767–775 (1996).
Thapar, M.A., Parr, E.L. & Parr, M.B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology 70, 121–125 (1990).
Moore, J.P. et al. Inter- and intraclade neutralization of human immunodeficiency virus type 1: Genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J. Virol. 70, 427–444 (1996).
Brinchmann, J.E., Gaudernack, G. & Vartdal, F. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. J. Immunol. 144, 2961–2966 (1990).
Copeland, K.F.T., McKay, P.J. & Rosenthal, K.L. Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific. AIDS Res. Hum. Retrovir. 11, 1321–1326 (1995).
Otsyula, M.G. et al. Fetal or neonatal infection with attenuated simian immunodeficiency virus results in protective immunity against oral challenge with pathogenic SIVmac251. Virology (in the press).
Lohman, B.L., Miller, C.J. & McChesney, M.B. Antiviral cytotoxic T lymphocytes in the vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155, 5855–5860 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miller, C., Mcghee, J. Progress towards a vaccine to prevent sexual transmission of HIV. Nat Med 2, 751–752 (1996). https://doi.org/10.1038/nm0796-751
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0796-751
This article is cited by
-
Large intestine–targeted, nanoparticle-releasing oral vaccine to control genitorectal viral infection
Nature Medicine (2012)
-
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
Nature Medicine (2000)
-
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
Nature Medicine (1997)
-
Multi-epitope DNA vaccines
Immunology and Cell Biology (1997)